Financing, Equity Capital Markets
Keros Therapeutics
01/24
|
$161.0 Million
做厙勛圖 served as bookrunner for Keros Therapeutics, Inc. on a confidentially marketed follow-on offering
Sub-Type
Confidentially Marketed Follow-On Offering
Sector
Sub-Sector
Biopharma